This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Retail Clinics 2012: Growth Of Stores, Consumer Opinion Surveys, Winning Competitors, Supplier Sales Of Products To Clinics, Clinic Sales Forecasts And Trends

Figure 3-2: Kalorama Survey:" If You Have Not Visited a Retail Clinic How Likely Would You Be To Do So? "(Very, Somewhat, Not Sure, Somewhat Unlikely, Very Unlikely).

Figure 3-3: Gender Breakdown – Retail Clinic "Phobes" (Male, Female)

Figure 3-4: Gender Breakdown: Retail Clinic "Fans" (Male, Female)

Table 3-5: Type of Consumers More Willing to Try Retail Clinics .


Table 5-1: The U.S. Market for Retail Clinic Services, 2010–2017 (# of Locations, Patient Visits, Revenue Per Patient, Total Sales)

Table 5-2: U.S. Professional POC Test Sales to Retail Clinics, 2010-2017 whole or in any part, is strictly prohibited.

Table 5-3: U.S. Clinical Chemistry and Immunoassay Sales to Convenience Clinics, 2010-2017

Table 5-4: U.S. Vaccine Sales to Convenience Clinics, 2010–2017

Table 5-5: Indirect Income Generated by Retail Clinics, 2010–2017

To order this report: Medical_Facility Industry: Retail Clinics 2012: Growth of Stores, Consumer Opinion Surveys, Winning Competitors, Supplier Sales of Products to Clinics, Clinic Sales Forecasts and Trends______________________Contact Nicolas: nicolasbombourg@reportlinker.comUS: (805)-652-2626Intl: +1 805-652-2626


SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
4 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.02 0.00%
FB $104.07 0.00%
GOOG $683.57 0.00%
TSLA $162.60 0.00%
YHOO $27.97 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs